The partnership will expand J&J’s sports medicine platform and enhance its soft tissue portfolio, according to a Nov. 14 press release.
The agreement aims to offer providers more comprehensive tools for their evolving needs, and deliver innovative solutions that elevate patient outcomes, according to the release.
